Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.
about
Selective use of vandetanib in the treatment of thyroid cancer.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.The role of body image dissatisfaction in the association between treatment-related scarring or disfigurement and psychological distress in adult survivors of childhood cancer.Measuring Oral Mucositis of Pediatric Patients with Cancer: A Psychometric Evaluation of Chinese Version of the Oral Mucositis Daily Questionnaire.CME Part 1: Hair disorders in cancer patients.
P2860
Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Dermatologic adverse events in ...... therapies: a pooled analysis.
@ast
Dermatologic adverse events in ...... therapies: a pooled analysis.
@en
type
label
Dermatologic adverse events in ...... therapies: a pooled analysis.
@ast
Dermatologic adverse events in ...... therapies: a pooled analysis.
@en
prefLabel
Dermatologic adverse events in ...... therapies: a pooled analysis.
@ast
Dermatologic adverse events in ...... therapies: a pooled analysis.
@en
P2093
P2860
P50
P356
P1476
Dermatologic adverse events in ...... r therapies: a pooled analysis
@en
P2093
Christine A Pratilas
Courtney Washington
Vincent Sibaud
P2860
P304
P356
10.1002/PBC.25429
P577
2015-02-12T00:00:00Z